Landscape Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,780
Closed -$412K 701
2025
Q3
$412K Buy
+1,780
New +$362K 0.03% 485
2023
Q4
Sell
-9,237
Closed -$1.38M 823
2023
Q3
$1.38M Buy
9,237
+4,863
+111% +$714K 0.18% 112
2023
Q2
$589K Buy
+4,374
New +$641K 0.08% 218
2022
Q4
Sell
-7,134
Closed -$957K 839
2022
Q3
$957K Buy
+7,134
New +$1.02M 0.13% 138
2019
Q4
Sell
-73,437
Closed -$5.56M 612
2019
Q3
$5.56M Buy
+73,437
New +$5.03M 0.41% 51
2018
Q3
Sell
-15,556
Closed -$1.44M 688
2018
Q2
$1.44M Buy
+15,556
New +$1.52M 0.12% 139

Other funds holding ABBV

Landscape Capital Management's ABBV Position: Q4 2025 in Review

Landscape Capital Management sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 1,780 shares — an estimated $412K sold.

Landscape Capital Management first reported a position in ABBV in Q2 2018 and held it in 6 quarters. The position peaked at $5.56M in Q3 2019. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Landscape Capital Management reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Landscape Capital Management sold 1,780 AbbVie shares in Q4 2025, an estimated $412K.
  • Landscape Capital Management first reported a position in AbbVie in Q2 2018 and held it in 6 quarters.
  • Landscape Capital Management's AbbVie position peaked at $5.56M in Q3 2019.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Landscape Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.